Markers of inflammation in sepsis

References

• Ruokonen E, Takala J, Kari A, Alhava E. Septic shock and multiple organ failure. Crit Care Med 1991; 19: 1146–51.
   PubMed Web of Science ®Google Scholar
• Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995; 273: 117–23.
   PubMed Web of Science ®Google Scholar
• Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and not know about cytokine regulation. Crit Care Med 1996; 24: 163–72.
   PubMed Web of Science ®Google Scholar
• Nadel S. Helping to understand studies examining genetic susceptibility to sepsis. Clin Exp Immunol 2002; 127: 191–2.
   PubMedGoogle Scholar
• Varani J, Ward PA. Mechanisms of endothelial cell injury in acute inflammation. Shock 1994; 2: 311–9.
   PubMed Web of Science ®Google Scholar
• Piani A, Hossle JP, Birchler T, Siegrist CA, Heumann D, Davies G, et al. Expression of MHC class II molecules contributes to lipopolysaccharide responsiveness. Eur J Immunol 2000; 30: 3140–6.
   PubMed Web of Science ®Google Scholar
• Wolk K, Döcke WD, von Baehr V, Volk HD, Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000; 96: 218–23.
   PubMed Web of Science ®Google Scholar
• Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644–55.
   PubMed Web of Science ®Google Scholar
• Takala A, Jousela I, Olkkola KT, jansson SE, Leirisalo-Repo M, Takkunen O, et al. Systemic inflammatory response syndrome without systemic inflammation in acutely ill patients admitted to hospital in a medical emergency. Clin Sci 1999; 96: 287–95.
   Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–29.
   PubMed Web of Science ®Google Scholar
• Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, et al. The use of maximum SOFA score to quatify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Intensive Care Med 1999; 25: 686–96.
   PubMed Web of Science ®Google Scholar
• Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23: 1638–52.
   PubMed Web of Science ®Google Scholar
• Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002; 23: 301–4.
   PubMed Web of Science ®Google Scholar
• Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347: 185–92.
   PubMed Web of Science ®Google Scholar
• Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103: 565–75.
   PubMed Web of Science ®Google Scholar
• HYlminen M, Valtonen M, Vaara M, Markkanen H, Kuusela P, Saxen H, et al. Plasma endotoxin and cytokine levels in neutropenic and non-neutropenic bacteremic patients. Eur J Clin Microbiol Infect Dis 1995; 14: 1039–45.
   PubMedGoogle Scholar
• Castell JV, Gomez-lechon MJ, David M, Hirano T, Kishimoto T, Heinrich PC. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988; 232: 347–50.
   PubMed Web of Science ®Google Scholar
• Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000; 117: 1162–72.
   PubMed Web of Science ®Google Scholar
• Luster AD. Mechanisms of disease: chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436–45.
   PubMed Web of Science ®Google Scholar
• Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135: 3172–7.
   PubMed Web of Science ®Google Scholar
• Rubin LA, Nelson DL The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 1990; 113: 619–27.
   PubMed Web of Science ®Google Scholar
• Coombes RC, Hillyard C, Greenberg PB, MacIrityre I. Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet 1974; 1: 1080–3.
   PubMed Web of Science ®Google Scholar
• Assicot M, Gendrel D, Carsin H, Raymond J, Guilband J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515–8.
   PubMed Web of Science ®Google Scholar
• Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, et al. Procalcitonin expresion in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999; 134: 49–55.
   PubMed Web of Science ®Google Scholar
• Nijsten MWN, Olinga P, The TH, de Vries EGE, Koops HS, Groothuis GMM, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000; 28: 458–61.
   PubMed Web of Science ®Google Scholar
• Repo H, Harlan JM. Mechanisms and consequences of phagocyte adhesion to endothelium. Ann Med 1999; 31: 156–65.
   PubMed Web of Science ®Google Scholar
• Koppehnan B, Neefjes JJ, de Vries JE, de Waal Malefyt R. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 1997; 7: 861–71.
   Google Scholar
• Diicke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, et al. Monocyte deactivation in septic patients: restoration by IFN-y treatment. Nat Med 1997; 3: 678–81.
   PubMedGoogle Scholar
• Takala A, Jousela I, Jansson SE, Olkkola KT, Takkunen O, Orpana A, et al. markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin Sci 1999; 97: 529–38.
   Google Scholar
• Meisner M, Tschaikowsky K, Pahnaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999; 3: 45–50.
   PubMed Web of Science ®Google Scholar
• Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27: 498–504.
   PubMed Web of Science ®Google Scholar
• Schroder J, Staubach KH, Zapel P, Stuber F, Kremer B. Procalcitonin as a marker of severity in septic shock. Langenbecks Arch Surg 1999; 384: 33–8.
   PubMed Web of Science ®Google Scholar
• Tschaikowsky K, Hedwig-Geissing M, Schiele A, Bremer F, Schywalsky M, Schuttler J. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 2002; 30: 1015–23.
   PubMed Web of Science ®Google Scholar
• van Dissel JT, van Langevelde P, Westendorp RGJ, Kwappenberg K, Fröfich M. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998; 351: 950–3.
   PubMed Web of Science ®Google Scholar
• Ditschkowsky M, Kreuzfelder E, Rebmann V, Ferencik S, Majetschak M, Schmid EN, et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg 1999; 229: 246–54.
   PubMedGoogle Scholar
• Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ Changes in major histocompatibility complex class II expression in monocytes and T cells developing infection after surgery. Br J Surg 1993; 80: 205–9.
   PubMed Web of Science ®Google Scholar
• Kono K, Sekikawa T, Matsumoto Y. Influence of surgical stress on monocytes and complications of infection in patients with esophageal cancer - monocyte HLA-DR antigen expression and respiratory burst capacity. J Surg Res 1995; 58: 275–80.
   PubMedGoogle Scholar
• Munford RS, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001; 163: 316–21.
   PubMed Web of Science ®Google Scholar
• Cavaillon JM, Adip-Conquy M, Cloez-Tayarani I, Fitting C. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. J Endotoxin Res 2001; 7: 85–93.
   PubMedGoogle Scholar
• Tenner S, Sica G, Hughes M, Noordhoek E, Feng S, Zinner M, Banks PA. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997; 113: 899–903.
   PubMed Web of Science ®Google Scholar
• Takala A, Jousela I, Takkunen O, Kautiainen H, jansson SE, Orpana A, et al. A prospective study of inflammation markers in patients at risk of indirect acute lung injury. Shock 2002; 17: 252–7.
   PubMedGoogle Scholar
• Neoptolemos JP, Raraty M, Finch M, Sutton R. Acute pancreatitis: the substantial human and financial costs. Gut 1998; 42: 886–91.
   PubMed Web of Science ®Google Scholar
• Schmid SW, Uhl W, Friess H, Maltertheiner P, Buchler MW. The role of infection in acute pancreatitis. Gut 1999; 45: 311–6.
   PubMed Web of Science ®Google Scholar
• Kylänpää-Back ML, Takata A, Kemppainen EA, Puolakkainen PA, Leppäniemi AK, Karonen SL, et al. Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001; 29: 63–9.
   PubMed Web of Science ®Google Scholar
• Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP, McKay C, et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001; 48: 62–9.
   PubMed Web of Science ®Google Scholar
• Puolakkainen P, Valtonen V, Paananen A, Schroder T. reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity os acute pancreatitis. Gut 1987; 28: 764–71.
   PubMed Web of Science ®Google Scholar
• Neoptolemos JP, Kemppainen EA, Mayer JM, Fizpatrick JM, Raraty MG, Slavin J, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000; 355: 1955–60.
   PubMed Web of Science ®Google Scholar
• Kylanpaa-Back ML, Takala A, Kemppainen E, Puolakkainen P, Kautiainen H, Jansson SE, et al. Cellular markers of systemic inflammation and immune suppression in patients with organ failure due to severe acute pancreatitis. Scand J Gastroenterol 2001; 36: 1100–7.
   PubMed Web of Science ®Google Scholar
• Ikei S, Ogawa M, Yamaguchi Y. Blood concentrations of polymorphonuclear leucocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at early stage of acute pancreatitis. J Gastroenterol Hepatol 1998; 13: 1274–83.
   PubMed Web of Science ®Google Scholar
• Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998; 175: 76–83.
   PubMedGoogle Scholar
• Garcia-Sabrido JL, Valdecantos E, Bastida E, Tellado JM. The anergic state as a predictor of pancreatic sepsis. Zentralbl Chir 1989; 114: 114–20.
   PubMedGoogle Scholar
• Simovic MO, Bonham MJ, Abu-Zidan FM, Windsor JA. Anti-inflammatory cytokine response and clinical outcome in acute pancreatitis. Crit Care Med 1999; 27: 2662–5.
   PubMedGoogle Scholar
• Toh SK, Phillips S, Johnson CD. A prospective audit against national standards of the presentation and management of acute pancreatitis in the South of England. Gut 2000; 46: 239–43.
   PubMed Web of Science ®Google Scholar
• Brivet FG, Emilie D, Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 1999; 27: 749–55.
   PubMed Web of Science ®Google Scholar
• Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 1997; 132: 620–5.
   PubMedGoogle Scholar
• Rhee P, Waxman K, Clark L, Kaupke CJ, Vaziri ND, Tominaga G, et al. Tumor necrosis factor and monocytes are released during hemorrhagic shock. Resuscitation 1993; 25: 249–55.
   PubMedGoogle Scholar
• Mileski WJ, Winn RK, Vedder NB, Pohlman TH, Harlan JM, Rice CL. Inhibition of CD18-dependent neutrophil adherence reduces organ injury after hemorrhagic shock in primates. Surgery 1990; 108: 206–12.
   PubMed Web of Science ®Google Scholar
• Botha AJ, Moore FA, Moore EE, Sauaia A, Banerjee A, Peterson VM. Early neutrophil sequestration after injury: a pathogenetic mechanism for multiple organ failure. J Trauma 1995; 39: 411–7.
   PubMed Web of Science ®Google Scholar
• Harlan JM, Winn RK. Leukocyte-endothelial interactions: clinical trials of anti-adhesion therapy. Crit Care Med 2002; 30 (5 Suppl.): S214–9.
   Google Scholar
• Engervall P, Granström M, Andersson B, Bjeorkholm M. Monitoring of endotoxin, interleukin-6, C-reactive protein serum concentrations in neutropenic patients with fever. Eur J Haematol 1995; 54: 226–34.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Gaspar M, Santolaria F, Jarque-Lopez A, Gonzalez-Reimers E, Milena A, de la Vega MJ, et al. Prognostic value of cytokines in SIRS general medical patients. Cytokine 2001; 15: 232–6.
   PubMedGoogle Scholar
• Chirouze C, Schuhmacher H, Rabaud C, Gil H, Khayat N, Estavoyer JM, et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 2002; 35: 156–61.
   PubMed Web of Science ®Google Scholar
• Rau B, Steinbach G, gansauge F, Mayer JM, Grunert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41: 832–40.
   PubMed Web of Science ®Google Scholar
• Ruse ER, Langefeld I, Jaeger K, Külpmann WR. Procalcitonin in fever of unknown origin after liver transplantation: A variable to differentiate acute rejection from infection. Crit Care Med 2000; 28: 555–9.
   PubMedGoogle Scholar
• Sabat R, Hoflich C, Docke WD, Oppert M, Kern F, Windrich B, et al. Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med 2001; 27: 987–91.
   PubMed Web of Science ®Google Scholar
• Headley AS, Tolley E, Meduri GU. Infections and the inflammatory response in acute respiratory distress syndrome. Chest 1997; 111: 1306–21.
   Google Scholar
• Suprin E, Camus C, gacouin A, Le Tulzo Y, Lavoue S, Feuillu A, Thomas R. Procalcitonin: a valuable indicator of infection in a medical ICU. Intensive Care Med 2000; 26: 1232–8.
   PubMed Web of Science ®Google Scholar
• Ruokonen E, Ilkka L, Niskanen M, Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 2002; 46: 398–404.
   PubMed Web of Science ®Google Scholar
• Da Silva O, Ohlsson A, Kenyon C. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review. Pediatr Infect Dis J 1995; 14: 362–6.
   PubMed Web of Science ®Google Scholar
• Berner R, Niemeyer CM, Leititis JU, Funke A, Schwab C, Rau U, et al. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, inter-leukin (IL)-1-beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res 1998; 44: 469–77.
   PubMed Web of Science ®Google Scholar
• Franz A, Kron M, Pohlandt F, Steinbach G. Comparison of procalcitonin with interleukin 8, C-reactive protein and white blood cell count for the early diagnosis of bacterial infections in newborn infants. Pediatr Infect Dis J 1999; 18: 666–71.
   PubMed Web of Science ®Google Scholar
• Nupponen I, Andersson S, Järvenpää AL, Kautiainen H, Repo H. Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis. Pediatrics 2001; 108: E12. Mirzabekov A, Kolchinsky A. Emerging array-based technologies in proteomics. Curr Opin Chem Biol 2002; 6: 70–5.
   PubMedGoogle Scholar